Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 178

1.

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.

Kapur S, Zipursky R, Jones C, Shammi CS, Remington G, Seeman P.

Arch Gen Psychiatry. 2000 Jun;57(6):553-9.

PMID:
10839333
[PubMed - indexed for MEDLINE]
2.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
[PubMed - indexed for MEDLINE]
3.

Implications of brain imaging for the management of schizophrenia.

Nyberg S, Nilsson U, Okubo Y, Halldin C, Farde L.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S15-20. Review.

PMID:
9690965
[PubMed - indexed for MEDLINE]
4.

A new framework for investigating antipsychotic action in humans: lessons from PET imaging.

Kapur S.

Mol Psychiatry. 1998 Mar;3(2):135-40. Review.

PMID:
9577837
[PubMed - indexed for MEDLINE]
5.

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.

Kapur S, Seeman P.

Am J Psychiatry. 2001 Mar;158(3):360-9. Review.

PMID:
11229973
[PubMed - indexed for MEDLINE]
6.
7.

[Receptor occupancy and antipsychotic drug action measured by PET and SPECT].

Okubo Y, Suhara T.

Seishin Shinkeigaku Zasshi. 2001;103(4):329-40. Review. Japanese.

PMID:
11392846
[PubMed - indexed for MEDLINE]
8.

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T.

World J Biol Psychiatry. 2002 Jul;3(3):133-46. Review.

PMID:
12478878
[PubMed - indexed for MEDLINE]
9.

Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis.

Lako IM, van den Heuvel ER, Knegtering H, Bruggeman R, Taxis K.

J Clin Psychopharmacol. 2013 Oct;33(5):675-81. doi: 10.1097/JCP.0b013e3182983ffa. Review.

PMID:
23948784
[PubMed - indexed for MEDLINE]
10.

Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia.

Kasper S, Tauscher J, Küfferle B, Barnas C, Pezawas L, Quiner S.

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 4:83-9. Review.

PMID:
10654113
[PubMed - indexed for MEDLINE]
11.

Antipsychotic efficacy: relationship to optimal D2-receptor occupancy.

Pani L, Pira L, Marchese G.

Eur Psychiatry. 2007 Jul;22(5):267-75. Epub 2007 Apr 6. Review.

PMID:
17419008
[PubMed - indexed for MEDLINE]
12.

Imaging of receptors in clinical neurosciences.

Korf J.

Acta Neurol Belg. 1997 Sep;97(3):200-5. Review.

PMID:
9345594
[PubMed - indexed for MEDLINE]
13.

Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.

Nemeroff CB, Kinkead B, Goldstein J.

J Clin Psychiatry. 2002;63 Suppl 13:5-11. Review.

PMID:
12562141
[PubMed - indexed for MEDLINE]
14.

The current status of PET scanning with respect to schizophrenia.

Sedvall G.

Neuropsychopharmacology. 1992 Aug;7(1):41-54. Review.

PMID:
1388021
[PubMed - indexed for MEDLINE]
15.

Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench.

Kapur S, Wadenberg ML, Remington G.

Can J Psychiatry. 2000 Apr;45(3):241-6. Review.

PMID:
10779880
[PubMed - indexed for MEDLINE]
16.

The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.

Stahl SM, Shayegan DK.

J Clin Psychiatry. 2003;64 Suppl 19:6-12. Review.

PMID:
14728084
[PubMed - indexed for MEDLINE]
17.

Quetiapine. A review of its use in the management of schizophrenia.

Cheer SM, Wagstaff AJ.

CNS Drugs. 2004;18(3):173-99. Review.

PMID:
14871161
[PubMed - indexed for MEDLINE]
18.

Mechanism of new antipsychotic medications: occupancy is not just antagonism.

Grunder G, Carlsson A, Wong DF.

Arch Gen Psychiatry. 2003 Oct;60(10):974-7. Review.

PMID:
14557141
[PubMed - indexed for MEDLINE]
19.

The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.

Talbot PS, Laruelle M.

Eur Neuropsychopharmacol. 2002 Dec;12(6):503-11. Review.

PMID:
12468013
[PubMed - indexed for MEDLINE]
20.

[Theory in antipsychotic drug therapy for schizophrenia].

Tomioka S, Ishigooka J.

Seishin Shinkeigaku Zasshi. 2006;108(6):614-8. Review. Japanese.

PMID:
16910539
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk